Table 2.
Risk Estimates for Pancreatic Cancer Associated With Cigarette Smoking in the Pooled Study Population, With Never Smokers as the Reference Group
| Smoking Exposure | No. of Cases | No. of Controls | ORa | 95% CI |
| Never smoker | 582 | 678 | 1.00 | Referent |
| Ever smoker | 899 | 861 | 1.24 | 1.06, 1.46 |
| Current | 433 | 362 | 1.77 | 1.38, 2.26 |
| Former | 466 | 499 | 1.09 | 0.91, 1.30 |
| Intensity, cigarettes/day | ||||
| <10 | 142 | 149 | 1.18 | 0.91, 1.55 |
| 10–<20 | 252 | 239 | 1.33 | 1.05, 1.67 |
| 20–<25 | 150 | 145 | 1.30 | 0.98, 1.72 |
| 25–<30 | 70 | 68 | 1.28 | 0.88, 1.88 |
| ≥30 | 121 | 84 | 1.75 | 1.27, 2.42 |
| Ptrend | <0.001 | |||
| Duration, years | ||||
| ≤10 | 86 | 93 | 1.08 | 0.79, 1.49 |
| >10–20 | 113 | 139 | 0.96 | 0.72, 1.27 |
| >20–40 | 406 | 378 | 1.30 | 1.06, 1.60 |
| >40–50 | 161 | 134 | 1.59 | 1.20, 2.11 |
| >50 | 39 | 24 | 2.13 | 1.25, 3.62 |
| Ptrend | <0.001 | |||
| Pack-years | ||||
| ≤10 | 149 | 165 | 1.11 | 0.85, 1.43 |
| >10–20 | 121 | 115 | 1.32 | 0.98, 1.77 |
| >20–30 | 127 | 125 | 1.30 | 0.97, 1.75 |
| >30–40 | 119 | 107 | 1.49 | 1.08, 2.03 |
| >40 | 194 | 146 | 1.78 | 1.35, 2.34 |
| Ptrend | <0.001 | |||
| Years since quitting | ||||
| 1–<10 | 40 | 20 | 2.19 | 1.25, 3.83 |
| 10–<15 | 40 | 37 | 1.24 | 0.78, 1.98 |
| 15–<20 | 36 | 47 | 0.91 | 0.58, 1.44 |
| 20–<30 | 81 | 104 | 0.91 | 0.66, 1.26 |
| ≥30 | 154 | 198 | 0.93 | 0.73, 1.20 |
| Ptrend | <0.001 | |||
| 1–<10b | 40 | 20 | 1.24 | 0.69, 2.22 |
| 10–<15 | 40 | 37 | 0.70 | 0.43, 1.16 |
| 15–<20 | 36 | 47 | 0.52 | 0.32, 0.85 |
| 20–<30 | 81 | 104 | 0.52 | 0.36, 0.75 |
| ≥30 | 154 | 198 | 0.53 | 0.39, 0.73 |
| Ptrend | <0.001 | |||
| Age at start, yearsc | ||||
| <15 | 68 | 64 | 1.24 | 0.85, 1.79 |
| 15–<20 | 361 | 346 | 1.27 | 1.03, 1.56 |
| ≥20 | 410 | 381 | 1.28 | 1.06, 1.56 |
| Ptrend | 0.97 | |||
Abbreviations: CI, confidence interval; OR, odds ratio.
Models were adjusted for age, sex, study center, diabetes, body mass index, and race.
Years since quitting using current smokers as the reference group.
Data were missing for the CLUE II study.